Funding Opportunity: ADDF-Harrington Scholar Award
URL: https://www.harringtondiscovery.org/funding/addf-harrington
OBJECTIVES:
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute provide funding and drug development support of research efforts that aim to treat or prevent Alzheimer’s disease, related dementias and cognitive-decline associated with aging. Each year up to two ADDF-Harrington Scholars are chosen. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and senescence. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are strongly encouraged to apply. In addition to grant funding, Harrington Discovery Institute provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.
FUNDING INFORMATION:
The award includes:
- Two-year grant
- Funding up to $600,000
- Opportunity to qualify for investment funds
- Drug development expertise and project management support
- A personalized team of drug developers and project manager for each award recipient
- Expert business, commercialization and clinical development advice
- Regulatory assistance
- Intellectual property (IP) review and advice
- Assistance identifying and securing additional financial support based on project needs
Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.
ELIGIBILITY REQUIREMENTS:
- MD or PhD (or equivalent)
- Faculty position at an accredited academic medical center, university or research institution in the US, Canada or the UK, and conduct the majority of his/her/their research at that institution
- Proposals should support the development of a therapeutic that could treat, prevent, or slow Alzheimer’s disease or related dementias
- A project must have only a single Principal Investigator (PI), who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project.
- Past recipients of Harrington awards may submit new and distinct proposals, but may not seek additional support for previously funded projects.
DEADLINES:
Letter of Intent: June 3, 2024
Full Application Deadline for those Invited: August 26, 2024